Completed

Analysis of the Occurrence of Perilesional Edema and Seizures in Patients With Inactive Cysticercosis

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Who is being recruted

Cestode Infections+11

+ Helminthiasis

+ Infections

Over 18 Years
See all eligibility criteria
How is the trial designed

Observational
Study Start: August 1999
See protocol details

Summary

Principal SponsorNational Institute of Allergy and Infectious Diseases (NIAID)
Last updated: July 2, 2017
Sourced from a government-validated database.Claim as a partner

Study start date: August 10, 1999

Actual date on which the first participant was enrolled.

Seizures are the most common clinical manifestation of cerebral cysticercosis and occur in the presence of viable, dying, and calcified or non-calcified dead cysts. How calcified cysts provoke seizures is not known but recent observations demonstrated edema around some calcified lesions at the time of seizure activity and disappearance during periods when seizures were not occurring. Edema associated with foci in idiopathic epilepsy is highly unusual so that this observation suggests that the mechanism(s) associated with calcified cysts is unique. Documenting and understanding this phenomenon is important for a number of reasons. First, although by definition these lesions are inactive, e.g., not living larvae and do not require anti-parasitic treatment, they are frequently mistaken for active lesions and patients undergo unnecessary treatment. Second, a likely reason for perilesional edema is intermittent antigen release and subsequent host immune response resulting in inflammation and edema. If proved, then the treatment for this would not only involve suppression of seizure activity with anti-seizure medication but also the use of anti-inflammatory medications such as corticosteroids. The present protocol will systematically assess the presence of edema associated with calcified lesions at the time of seizure activity and attempt to determine why some calcified lesions in the same patient are foci of seizures while others are clinically silent. There are three related but separate questions. 1) What is the most sensitive MRI technique that can detect edema around calcified or inactive lesions? It is essential to determine the most sensitive methods initially because the use of insensitive techniques will lead to inaccurate assessments of which lesions are prone to lead to seizure activity and how many patients are affected. 2) How common is perilesional edema around calcified or inactive lesions associated with seizure activity? 3) What factors determine which lesions are prone to cause seizure activity? 4) Can perilesional edema be effectively treated or prevented? 5) Can perilesional edema be treated? We have reported from long term longitudinal studies in a handful of patients that only some of many lesions seem to be associated with seizure activity and edema.

NCT00001912
Principal SponsorNational Institute of Allergy and Infectious Diseases (NIAID)
Last updated: July 2, 2017
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

6 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Cestode InfectionsHelminthiasisInfectionsNeoplasmsNervous System DiseasesNeurologic ManifestationsParasitic DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsTaeniasisPathological Conditions, AnatomicalCysticercosisCystsSeizures

Criteria

INCLUSION CRITERIA: 18 years of age or older. If children are evaluated they can be seen under the general protocol and they may be entered into the present protocol under an exception. Likely diagnosis of inactive cysticercosis and present or past seizure activity. Requires "a" and "b" plus any one of the remaining criteria: History of seizures or present seizure activity; Previously treated or has inactive disease and declines treatment; Single calcified lesions and positive serology; Multiple calcified lesions; Multiple small enhancing nodular lesions; History of cystic lesions responding to specific chemotherapy. If female, not pregnant and using effective birth control methods. EXCLUSION CRITERIA: Less than 18 years of age. Pregnant or unwilling to use effective birth control measures. Refuse blood tests. Unwilling or unable to undergo testing according to the schedule. Unable to undergo MRI or CT examinations. Patients who require anesthesia to undergo imaging studies.

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 2 locations

National Institutes of Health Clinical Center, 9000 Rockville Pike

Bethesda, United StatesOpen National Institutes of Health Clinical Center, 9000 Rockville Pike in Google Maps

Universidad Peruana Cayetano Heredia

Lima, Peru
Completed2 Study Centers